G-A-Y Bar, a nightlife fixture in London’s Soho, turned into a pop-up sexual health clinic last week, offering vaccines and DoxyPEP to hundreds of patrons. The popular gay bar partnered with 56 Dean Street, an NHS clinic specializing in sexual health and HIV prevention, to host the September 18 event, with another scheduled for September 25.
The first pop-up drew about 550 people, with lines stretching down Old Compton Street. Inside, booths were turned into makeshift consultation rooms where patrons received advice, as pop anthems played, reports the BBC.
Lawrence O’Connell, a senior nurse at 56 Dean Street, said the goal of the pop-up is to reduce stigma and anxiety around sexual health and to meet people where they are.
According to the BBC, gay and bisexual men accounted for 75% of syphilis and 70% of gonorrhea cases in London last year. Nationwide, gonorrhea diagnoses hit a record high of more than 85,000 in 2023 — triple the 2012 figure — before dropping to 71,000. Health experts warn of a growing number of antibiotic-resistant cases, while syphilis has also continued to rise.
The vaccine offered, Bexsero, was originally developed to protect against meningitis B. Recent studies suggest it may cut the risk of gonorrhea by about 40%. Two doses are needed for full protection.
Alongside the vaccine, health workers prescribed DoxyPEP, a dose of doxycycline that, when taken within 72 hours of unprotected sex, lowers the risk of STIs such as chlamydia and syphilis. It is currently recommended only for gay and bisexual men and trans women who have recently had an STI or who regularly have new or multiple partners.
O’Connell cautioned that the vaccine and DoxyPEP should not be seen as standalone solutions, but used alongside other prevention methods such as condoms or PrEP.
The D.C. Council has voted unanimously to advance a bill requiring health insurance companies to cover the cost of HIV prevention drugs, including medications used for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP).
The vote came after the Council unanimously approved an amendment removing language added in committee that would have required insurers to fully cover only one PrEP drug of their choosing.
The amended bill now states that, for plans issued or renewed after January 1, 2027, an insurer "may not impose cost sharing, require prior authorization, or impose any medically unnecessary restrictions or delays for the coverage of HIV prevention services, PEP, or any formulation of PrEP approved by the FDA."
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.